• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Store » Books » The Revised Common Rule: New Requirements for Clinical Trials
The Revised Common Rule: New Requirements for Clinical Trials : PDF

The Revised Common Rule: New Requirements for Clinical Trials

$397.00
Books

Product Details

After much discussion and repeated postponements, the updated Common Rule took effect on January 21, 2019.

The new, widely-revised rule will have an impact on virtually all clinical research procedures, including:

  • The definition of research in policies and procedures, which should be updated to reflect the new definition of research with its additional carve-outs
  • The definition of “human subject,” which should now include “identifiable biospecimen”
  • Procedures and conditions for limited IRB review
  • IRB continuing review policy to allow for the new exceptions
  • IRB expedited review procedures
  • The waiver process to address broad consent
  • Screening and recruitment policies.

In The Revised Common Rule report two prominent healthcare attorneys sift through the new rule to mark out every deletion –highlight every addition –interpret every rewording –that clinical research professionals and institutions need to understand to comply. You’ll learn:

  • New requirements for consent documents and elements of informed consent
  • Broad consent from subjects for secondary research involving identifiable private information and identifiable biospecimens
  • Limited IRB review of exempt research, expedited review and the criteria for IRB approval of research
  • New and modified exemptions
  • SOP updates you will need to make to accommodate Common Rule changes

This report provides a roadmap to future Common Rule compliance, outlining all the new and revised requirements in areas such as:

  • Broad consent for secondary research
  • Informed consent
  • IRB review
  • Exemptions
  • Cooperative research

Order your copy of The Revised Common Rule: New Requirements for Clinical Trials report and know the impact of revisions on your clinical trials and start planning now.

Who Will Benefit

  • Institutional Officials
  • Clinical operations staff
  • IRB staff and members
  • Principal investigators
  • Study coordinators
  • Clinical research associates

PDF

$397.00
Add to Cart

ISBN-13:
9978-1-60430-085-7

Publication date:
August 2018

Page count:
215


Our Guarantee
Not satisfied with your publication? For the PDF version, you must notify CenterWatch within 24 hours of receipt of purchase and we will refund 100 percent of your purchase price.

  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing